Watch the next video segment here MIAMI, FL / ACCESS Newswire / December 3, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage privately-held biotechnology company focused on the ...

The Cleveland Clinic is studying the impact artificial intelligence has on diabetes research and treatment. "There are many ...

Primary care practices continue to see a growing number of patients with diabetes, particularly in rural areas where rates of diabetes tend to be higher than in metropolitan areas. And for the most ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But with the growing popularity and effectiveness of medications like semaglutide ...

At Diabetes & Endocrinology Clinic at the Gym with Dr. Karl Nadolsky, patients being treated for or at risk of diabetes are ...

Please provide your email address to receive an email when new articles are posted on . AI in diabetes care may help with diagnosis prediction and facilitate administration for clinicians. It is ...

BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes The first two type 1 diabetes patients enrolled in ...